News

Article summarySickle Cell Disease (SCD) poses a significant health challenge in low- and middle-income countries, particularly in sub-Saharan Africa, where access…

OverviewJoin our virtual 5K Charity Run to raise awareness for MS & Sickle Cell, plus a chill post-run shakeout!5K Charity Run: Post Marathon Shake OutGet ready…

AbstractKey points: Renin-angiotensin system inhibitor use was not associated with slowed GFR decline in sickle cell disease. This null association did not change…

Health experts and medical researchers have urged swift and unified efforts to tackle the rising impact of sickle cell disease in Nigeria and throughout Sub-Saharan…

The Consortium on Newborn Screening in Africa (CONSA), launched by the American Society of Hematology in 2020, is designed to initiate and expand sustainable…

AbstractImportance: Sickle cell disease (SCD) disproportionately affects racial and ethnic minority groups in the US and is associated with high levels of morbidity…

About 100,000 Americans have sickle cell disease (SCD), the most common inherited blood disorder in the US.Roughly 10% of patients reside in New York State, with…

Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10% of people with SCD in the US live in New York State,…

Sickle cell disease (SCD) is one of the most common inherited blood disorders worldwide, impacting millions of people globally and most…

The wide interindividual variability in clinical response to hydroxyurea therapy in the management of sickle cell disease has limited its use. These variabilities…